Wednesday, July 30, 2025
Your Health 247
Advertisement
  • Home
  • Health
  • Fitness
  • Diseases
  • Nutrition
  • Weight Loss
  • Meditation
  • Wellbeing Tips
  • Suppliments
  • Yoga
No Result
View All Result
  • Home
  • Health
  • Fitness
  • Diseases
  • Nutrition
  • Weight Loss
  • Meditation
  • Wellbeing Tips
  • Suppliments
  • Yoga
No Result
View All Result
Your Health 247
No Result
View All Result
Home Health

Sarepta, Eli Lilly, SSRI effects, NIH, Bristol

Your Health 247 by Your Health 247
July 25, 2025
in Health
0 0
0
Sarepta, Eli Lilly, SSRI effects, NIH, Bristol
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter


Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Morning. Today, we discuss how Duchenne patients and their families are responding to the shelving of Sarepta Therapeutics’ gene therapy, see an FDA panel made up largely of SSRI skeptics lambast their use in pregnancy, and more.

The need-to-know this morning

European regulators said Sarepta Therapeutics’ Duchenne muscular dystrophy gene therapy should not be approved, further imperiling the future of the treatment, which is also facing increasing scrutiny in the U.S. Roche has commercial rights to the gene therapy, called Elevidys, in Europe and other countries. 

European regulators said Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for a select group of patients, changing course from an initial recommendation to reject the drug. 

Bristol Myers Squibb named Cristian Massacesi as its new chief medical officer. Massacesi is a phyisican and most recently served as chief medical officer at AstraZeneca and its Alexion unit. He replaces Samit Hirawat, who served as Bristol’s CMO for the past six years. 

Families devastated after FDA halts Sarepta gene therapy

Families of boys with Duchenne muscular dystrophy were devastated when the Food and Drug Administration asked Sarepta Therapeutics to halt shipments of its gene therapy, Elevidys, citing safety concerns — and the company subsequently agreed earlier this week. Parents who had fought for months to secure access are now stuck in limbo, with appointments abruptly canceled and little communication from regulators, STAT’s Jason Mast reports.

STAT+ Exclusive Story

Already have an account? Log in

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe



Source link

Tags: BristolEffectsEliLillyNIHSareptaSSRI
Previous Post

Do You Really Need 10,000 Steps a Day to Lose Weight? Here’s What Science Says

Next Post

Laminin-411 peptide shows promise for central nervous system myelin repair

Next Post
Laminin-411 peptide shows promise for central nervous system myelin repair

Laminin-411 peptide shows promise for central nervous system myelin repair

Facebook Twitter Instagram Youtube RSS
Your Health 247

Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!

CATEGORIES

  • Diseases
  • Fitness
  • Health
  • Meditation
  • Nutrition
  • Suppliments
  • Weight Loss
  • Wellbeing Tips
  • Yoga
No Result
View All Result

SITEMAP

  • About Us
  • Advertise with Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Health
  • Fitness
  • Diseases
  • Nutrition
  • Weight Loss
  • Meditation
  • Wellbeing Tips
  • Suppliments
  • Yoga

Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In